Brief: Day One Biopharmaceuticals Inc Announces VRK1 License Agreement And Research Collaboration With Sprint Bioscience

Day One Biopharmaceuticals

16/08/2023 13:11

Aug 16 (Reuters) - Day One Biopharmaceuticals Inc
 DAWN.O :
    * DAY ONE ANNOUNCES VRK1 LICENSE AGREEMENT AND RESEARCH
COLLABORATION WITH SPRINT BIOSCIENCE
    * DAY ONE BIOPHARMACEUTICALS: ENTERED EXCLUSIVE, WORLDWIDE
LICENSE
AGREEMENT AND RESEARCH COLLABORATION WITH SPRINT BIOSCIENCE FOR
ITS VRK1 PROGRAM
    * DAY ONE BIOPHARMACEUTICALS INC: WILL MAKE AN UPFRONT
PAYMENT OF
$3 MILLION TO SPRINT BIOSCIENCE
    * DAY ONE BIOPHARMACEUTICALS INC: WILL REIMBURSE SPRINT
BIOSCIENCE
FOR PRE-CLINICAL RESEARCH AND DEVELOPMENT EXPENSES
    * DAY ONE BIOPHARMACEUTICALS INC: SPRINT BIOSCIENCE WILL BE
ELIGIBLE TO RECEIVE ADDITIONAL MILESTONE PAYMENTS OF UP TO
APPROXIMATELY $313 MILLION

Source text for Eikon:  ID:nGNX14rgSN 
Further company coverage:  DAWN.O 

 ((reuters.briefs@thomsonreuters.com;))